Kaplan-Meier survival curves showed that the mean disease-free survival time in NPC patients with high expression of ARHGEF3 was significantly shorter than in patients with low expression of ARHGEF3 (P=0.001, long-rank test, Figure 1C, Table 2). Here, ARHGEF3 is linked to nasopharyngeal carcinoma.